Temocillin versus standard care for asymptomatic gonorrhea
Treatments studied
Part of Infections clinical trials.
This study tests whether an antibiotic called temocillin works as well as standard treatment for gonorrhea that has no symptoms. You may qualify if you've tested positive for gonorrhea but don't have signs of infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Positive test for Neisseria gonorrhoeae (gonorrhea) from urine, vaginal, throat, or rectal sample
- No symptoms of gonorrhea infection
- No severe allergy to penicillin-type antibiotics
- Not pregnant, breastfeeding, or planning pregnancy during the study
- Fluent in French, English, or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the antibiotic temocillin works in children with a kidney infection caused by certain bacteria. It may help doctors give the right dose for better treatment.
This study compares two antibiotics—piperacillin-tazobactam or temocillin—to treat severe ICU infections caused by certain hard-to-treat gut bacteria (ESBL). It may help patients avoid the use of carbapenem antibiotics like meropenem when the bacteria are susceptible.
This trial is testing a new way to use special tests (called integrons) to help doctors decide if they can safely use fewer strong antibiotics for urinary tract infections that are resistant to common treatments. It is for people in the hospital who have a resistant infection and may help reduce side effects and prevent more resistance.
This trial is testing whether a lower dose (500 mg) of the antibiotic ceftriaxone works as well as the standard dose (1000 mg) for treating gonorrhea in men. If you have a gonorrhea infection in your throat, rectum, or genitals and are otherwise healthy, you may be able to join.
This trial tests a new vaccine designed to protect against gonorrhea, a common sexually transmitted infection. The study checks how safe the vaccine is and how well it trains the immune system to fight the bacteria.
This trial tests a combination of medications (doxycycline, pentoxifylline, and nitazoxanide) in men with untreated gonorrhea and chlamydia. It may help clear the infection more effectively, but you must meet specific safety and health criteria.
Hear when a new Neisseria Gonorrhoeae (Ng) Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.